Drugs With No Patents And No Competition: Here’s Why
October 24, 2017Comments Off on Drugs With No Patents And No Competition: Here’s Why Posted in: Insights
Aggressive generic delay practices are troubling because, unlike patent exclusivity, they do not promote any public interest Increasing the costs of drugs has emerged as a core strategy for pharmaceutical…
The post Drugs With No Patents And No Competition: Here’s Why appeared first on DrugPatentWatch - Make Better Decisions.